Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Tema Neuroscience and Mental Health ETF
MNTLNASDAQ
Sector
Healthcare
Region
US
AUM
11.60M
Fund Score
Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) Quotes, Forecast and News Summary
Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $27.66 |
| AUM | 11.60M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 53 |
| Market Cap | $59.35B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 29.41 |
| Prev. Close | $24.67 |
| Low | - |
| 52 Wk Low | $23.67 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 4.87 |
Recent News
FAQ
Q
How do I buy Tema Neuroscience and Mental Health ETF (MNTL) stock?
A
You can purchase shares of Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) through any online brokerage.
Q
Who are Tema Neuroscience and Mental Health ETF (MNTL) competitors?
A
There are no as such competitors for Tema Neuroscience and Mental Health ETF.
Q
What is the forecast, or price target, for Tema Neuroscience and Mental Health ETF (MNTL) stock?
A
There is no analysis for Tema Neuroscience and Mental Health ETF to provide a consensus price target.
Q
What is the current price for Tema Neuroscience and Mental Health ETF (MNTL)?
A
The stock price for Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL) is $24.67 last updated November 18, 2024 at 4:15 PM EST.
Q
Does Tema Neuroscience and Mental Health ETF (MNTL) pay a dividend?
A
There are no upcoming dividends for Tema Neuroscience and Mental Health ETF.
Q
When is Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) reporting earnings?
A
Tema Neuroscience and Mental Health ETF does not have any upcoming earnings scheduled.
Q
Is Tema Neuroscience and Mental Health ETF (MNTL) going to split?
A
There is no upcoming split for Tema Neuroscience and Mental Health ETF.
| Open | - |
| High | - |
| 52 Wk High | $27.66 |
| AUM | 11.60M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 53 |
| Market Cap | $59.35B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 29.41 |
| Prev. Close | $24.67 |
| Low | - |
| 52 Wk Low | $23.67 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 4.87 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Jan 22, 2024 |
| Managers | David Song Yuri Khodjamirian |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| VRTX | Vertex Pharmaceuticals... | 5.76% |
| REGN | Regeneron Pharmaceutic... | 5.45% |
| LLY | Eli Lilly & Co. | 4.91% |
| ALNY | Alnylam Pharmaceutical... | 4.85% |
| AS | Argenx Se Spon Adr Eac... | 4.77% |
| NBIX | Neurocrine Biosciences... | 4.54% |
| DNLI | Denali Therapeutics In... | 4.18% |
| BIIB | Biogen Inc. | 3.94% |
| IL | Teva Pharmaceutical In... | 3.81% |
| CRNX | Crinetics Pharmaceutic... | 3.43% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved